| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/16/2011 | US20110144195 Methods for synthesizing glycinols, glyceollins i and ii, compositions of selected intermediates, and therapeutic uses thereof |
| 06/16/2011 | US20110144194 Chromenone derivatives useful for the treatment of neurodegenerative diseases |
| 06/16/2011 | US20110144193 Pharmaceutical Composition Comprising Cinchonains Ia And Ib, Process For Preparing An Epimeric Mixture Of Cinchonains Ia And Ib, Use And Method For Reverting/Combating Ventricular Fibrillation |
| 06/16/2011 | US20110144192 Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria |
| 06/16/2011 | US20110144191 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 06/16/2011 | US20110144190 Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
| 06/16/2011 | US20110144189 Guanylhydrazone compounds, compositions, methods of making and using |
| 06/16/2011 | US20110144188 Salts of trimebutine and n-desmethyl trimebutine |
| 06/16/2011 | US20110144187 Aptamer inhibition of thrombus formation |
| 06/16/2011 | US20110144186 Ssx-2 peptides presented by hla class ii molecules |
| 06/16/2011 | US20110144185 Rna antagonists targeting hsp27 |
| 06/16/2011 | US20110144184 Preventing or treating viral infection using an inhibitor of the lsd1 protein, a mao inhibitor or an inhibitor of lsd1 and a mao inhibitor |
| 06/16/2011 | US20110144183 Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 06/16/2011 | US20110144182 Treatment of surgical adhesions |
| 06/16/2011 | US20110144181 Pharmaceutical Compositions of Amorphous Atorvasta and Process for Preparing Same |
| 06/16/2011 | US20110144180 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144179 Substituted Heterocyclic Mercaptosulfonamide Metalloprotease Inhibitors |
| 06/16/2011 | US20110144178 1 ,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| 06/16/2011 | US20110144177 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents |
| 06/16/2011 | US20110144176 Macrolides and methods for producing same |
| 06/16/2011 | US20110144174 Deuterium-enriched odansetron |
| 06/16/2011 | US20110144171 Thiopene containing analogues of fluconazole as antifungal agents and process for their preparation |
| 06/16/2011 | US20110144170 Fc RECEPTOR MODULATING COMPOUNDS AND COMPOSITIONS |
| 06/16/2011 | US20110144169 Inhibitors of cellular necrosis |
| 06/16/2011 | US20110144168 Oxazolidine derivatives as nmda antagonists |
| 06/16/2011 | US20110144167 Prolyl Hydroxylase Inhibitors |
| 06/16/2011 | US20110144165 Prodrug compounds useful as cannabinoid ligands |
| 06/16/2011 | US20110144164 Pyridone derivatives as NK3 antagonists |
| 06/16/2011 | US20110144163 Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents |
| 06/16/2011 | US20110144162 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/16/2011 | US20110144161 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
| 06/16/2011 | US20110144160 Antagonists of Prostaglandin D2 Receptors |
| 06/16/2011 | US20110144159 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 06/16/2011 | US20110144158 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 06/16/2011 | US20110144156 A3 adenosine receptor allosteric modulators |
| 06/16/2011 | US20110144155 8-hydroxyquinoline derivatives for the treatment of hematological malignancies |
| 06/16/2011 | US20110144154 Salts of 2-Substituted Quinolines |
| 06/16/2011 | US20110144153 Amide compound |
| 06/16/2011 | US20110144152 Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| 06/16/2011 | US20110144151 Novel process, salts, composition and use |
| 06/16/2011 | US20110144150 Bridged bicyclic rho kinase inhibitor compounds, composition and use |
| 06/16/2011 | US20110144149 Gemifloxacin process and polymorphs |
| 06/16/2011 | US20110144148 Acetylcholinesterase dual inhibitors |
| 06/16/2011 | US20110144147 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 06/16/2011 | US20110144146 Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor |
| 06/16/2011 | US20110144145 Methods for treating visceral fat conditions |
| 06/16/2011 | US20110144144 Ibuprofen and narcotic analgesic compositions |
| 06/16/2011 | US20110144143 pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 06/16/2011 | US20110144141 Hair Growth and/or Regrowth Compositions |
| 06/16/2011 | US20110144140 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 06/16/2011 | US20110144139 Hepsin inhibitors |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144137 method for preventing or alleviating the noxious effects resulting from toxicant exposure |
| 06/16/2011 | US20110144136 Novel adenine derivatives |
| 06/16/2011 | US20110144135 Compounds for Modulating TRPV3 Function |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144133 Substituted pyrimidone derivatives |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144131 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines |
| 06/16/2011 | US20110144130 Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl-penta-2,4-dienoic acid as a cosmetic |
| 06/16/2011 | US20110144129 3-Aminocyclopentanecarboxamides as Chemokine Receptor Agonists |
| 06/16/2011 | US20110144128 Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands |
| 06/16/2011 | US20110144127 Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 06/16/2011 | US20110144126 Compounds useful for inhibiting chk1 |
| 06/16/2011 | US20110144125 Anti-Arrhythmia Agents, Methods of Their Use, Methods of Their Identification and Kits Therefore |
| 06/16/2011 | US20110144124 Compounds and Compositions for Use as Modulators of Tau Aggregation and Alleviation of Tauopathies |
| 06/16/2011 | US20110144123 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters |
| 06/16/2011 | US20110144122 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 06/16/2011 | US20110144121 Bicyclic pyrazolo-heterocycles |
| 06/16/2011 | US20110144120 Phenyl-alkyl piperazines having tnf-modulating activity, preparation method, and therapeutic use thereof |
| 06/16/2011 | US20110144119 Oxazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144118 Antiviral salts |
| 06/16/2011 | US20110144117 Pharmaceutical Dosage Form Containing Tetrahydrobiopterin |
| 06/16/2011 | US20110144116 DERIVATIVES OF (BRIDGED PIPERAZINYL)-1-ALKANONE AND USE THEREOF AS p75 INHIBITORS |
| 06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/16/2011 | US20110144114 Substituted triazinone derivatives |
| 06/16/2011 | US20110144113 Triazolotriazines as kinase inhibitors |
| 06/16/2011 | US20110144112 Apoptosis promoters |
| 06/16/2011 | US20110144111 Pharmaceutical composition for preventing or treating diseases associated with beta-amyloid accumulation containing morpholin or piperazine based compounds having so3h or cooh as active ingredient |
| 06/16/2011 | US20110144110 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/16/2011 | US20110144109 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof |
| 06/16/2011 | US20110144108 Substituted piperidine compounds and methods of their use |
| 06/16/2011 | US20110144107 Compounds and compositions useful for the treatment of malaria |
| 06/16/2011 | US20110144106 Novel cyclopropane indolinone derivatives |
| 06/16/2011 | US20110144105 Azaindole glucokinase activators |
| 06/16/2011 | US20110144104 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as ccr3 receptor ligands |
| 06/16/2011 | US20110144103 Pyrrole compounds that modulate hsp90 activity |
| 06/16/2011 | US20110144102 Calcimimetic compound for use in the treatment of epithelial injury |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144100 Triazolopyridine compounds as pim kinase inhibitors |
| 06/16/2011 | US20110144099 Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| 06/16/2011 | US20110144098 Amino oxazine derivatives |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144096 Treating various disorders using trkb agonists |
| 06/16/2011 | US20110144095 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/16/2011 | US20110144094 Heterocyclic tetracyclic tetrahydrofuran derivatives |
| 06/16/2011 | US20110144093 Method of treating organophosphorous poisoning |
| 06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144091 Inhibitors of Diacylglycerol Acyltransferase |